| abstract |
The invention generally describes new bispecific antigen binding molecules for activating T cells and reorienting them to specific target cells. Furthermore, polynucleotides encoding said bispecific antigen binding molecules, vectors and host cells containing said polynucleotides, as well as methods for producing bispecific antigen binding molecules according to the invention, and methods of using said bispecific antigen binding molecules for treating a disease are described. |